Yes, and if the algorithm is so accurate at diagnosing all the...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 88 Last

Share
Profile

Follow
Richard OZ

116 Posts.

22/06/17

15:12

Post #: 25433112
Share

Originally posted by green8 ↑

A point to consider is, what accuracy level do we require for a commercial viable business?

-Doctors are buying stethoscopes to get ~ 50-60% accuracy.
-Hospitals spends $10,000’s on x-rays to get ~ 70% accuracy
-Patients pay doctors $100’s and wait days to get x-ray/sputum/blood results

Why wouldn’t you pay $5-$10 for an instant diagnosis from the conveniences of your own bed via telehealth to get over 90% accuracy for most respiratory diseases?

RAP have; over 90% accuracy for most respiratory related illnesses, and is faster, more convenient & cheaper than alternatives. In most cases, this will provide a more suitable option for patients than current diagnostic tools available which makes the business not only viable but very profitable given the large market size & scalability.

Also, its worth noting the FDA approval isn’t on accuracy alone. The above mentioned diagnostic alternatives are in practise at those low accuracy rates hence i think FDA is a given.

Expand

Yes, and if the algorithm is so accurate at diagnosing all the others, then pneumonia may well be indicated by a process of elimination: you have xyz symptoms but don't have croup, asthma, bronchiolitis, etc etc (all others on the list)...what respiratory ailments is left? Pneumonia. (Then further tests to determine the type.) Ruling out can be as useful as ruling in.

RAP Price at posting: 32.5¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 201 more messages in this thread...

First 88 Last

Add RAP (ASX) to my watchlist

Yes, and if the algorithm is so accurate at diagnosing all the...

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News